Daily Pill to Extend Senior Dogs’ Lifespan and Quality of Life Reaches Milestone

Imagine more healthy years with your dog. Scientists may be one step closer to making that possible—not just by extending lifespan, but by helping dogs feel their best for longer.

A new drug designed for senior dogs is now closer to approval in the U.S. The medication, called LOY-002, is a daily pill for dogs aged 10 and older. It aims to improve how their bodies function as they age, helping them stay healthier, more active, and enjoy more time with their families.

Recently, the U.S. Food and Drug Administration reviewed part of the drug’s safety data and gave it the green light, meaning early results suggest it appears safe when used as intended. So far, the drug has passed two of the three major steps required for conditional approval, with one final section—focused on manufacturing—still under review.

In testing, dogs taking the drug have been closely monitored, and no serious safety issues have been found—even at higher doses. A large ongoing study involving about 1,300 dogs across the U.S. is helping researchers gather more data.

The company behind the drug, Loyal, is aiming for a potential launch as early as 2026. Their goal isn’t just to help dogs live longer, but to improve their “health span”—the time they feel good, stay active, and enjoy life.

But Loyal isn’t the only team working on this challenge—and some researchers are taking a very different approach. The Dog Aging Project, a collaboration between Texas A&M University and University of Washington, is running its own large clinical trial known as TRIAD, which is testing a drug called rapamycin in aging dogs.

Earlier laboratory research suggests that rapamycin may help improve heart health, brain function, and mobility—and could even play a role in extending lifespan.

At the same time, a separate research program supported by the National Institutes of Health is helping power this work, making it the largest clinical trial ever conducted in veterinary medicine.

For dog owners, the potential impact is huge. For scientists studying aging, it could be even more groundbreaking.

If approved, LOY-002 could become the first drug ever designed to extend lifespan in any species.

For now, more testing is still needed—but this progress marks an exciting step toward helping our dogs live longer, healthier, and happier lives.